Biocartis Idylla BRAF Mutation Test

מדינה: סינגפור

שפה: אנגלית

מקור: HSA (Health Sciences Authority)

זמין מ:

ANDAMAN MEDICAL PTE. LTD.

סיווג:

Class C IVD

תוצרת:

Biocartis NV

איזור תרפויטי:

Pathology

סממני תרפויטית:

The Idylla™ BRAF Mutation Test, performed on the Biocartis Idylla™ System, is an in vitro diagnostic Test for the qualitative detection of V600E/E2/D and V600K/R/M mutations in codon 600 of the BRAF gene. The Idylla™ BRAF Mutation Test uses DNA liberated from formalin-fixed paraffin-embedded (FFPE) tissue sections from human melanoma tumor cells. The Test is a sample-to-result real-time PCR. The results of the Idylla™ BRAF Mutation Test may be useful for the physician to aid in identifying metastatic melanoma patients who may benefit from BRAF targeted therapy. The Idylla™ BRAF Mutation Test is not intended to diagnose metastatic melanoma. The physician shall take other disease factors into account, other than the patient’s mutation status, to make a therapy decision.

leaflet_short:

Models: Idylla Instrument - P0010, Idylla Console - P1010, Idylla BRAF Mutation Test - A0010/6

תאריך אישור:

2017-07-05